According to MedPage Today (6/14, George), “prescription stimulants used as cognitive enhancers by people without” attention-deficit/hyperactivity disorder (AD/HD)” appear to reduce “performance in complex everyday activities,” investigators concluded in the findings of a 40-participant, “double-blind randomized trial.” The cognitive enhancers studied included methylphenidate (Ritalin), dextroamphetamine (Dexedrine), and modafinil (Provigil).”
HealthDay (6/14, Thompson) reports that subjects of the study “took much longer to complete tasks because they acted in a more erratic, scattershot manner while they worked.” The findings were published online June 14 in the journal Science Advances.
Related Links:
— MedPage Today (requires login and subscription)
— “For Folks Without the Condition, Taking ADHD Meds to Get ‘Smarter’ Could Backfire,” Dennis Thompson, HealthDay, June 14, 2023